Author: Sharma, Praveen; Kumar, Ashish
Title: Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19 Cord-id: y5ziurm6 Document date: 2020_6_10
ID: y5ziurm6
Snippet: BACKGROUND AND AIMS: Liver involvement is common in COVID-19. Elevated aspartate and alanine amino transaminase (AST/ALT) and borderline increase in serum bilirubin and serum alkaline phosphatase (ALP) are the commonest findings. Patients with associated co morbid conditions like obesity, cardiovascular disease, renal disease, malignancy, hypertension and old age are prone to develop severe disease. Limited data is available in patients with COVID-19 and metabolic dysfunction associated fatty li
Document: BACKGROUND AND AIMS: Liver involvement is common in COVID-19. Elevated aspartate and alanine amino transaminase (AST/ALT) and borderline increase in serum bilirubin and serum alkaline phosphatase (ALP) are the commonest findings. Patients with associated co morbid conditions like obesity, cardiovascular disease, renal disease, malignancy, hypertension and old age are prone to develop severe disease. Limited data is available in patients with COVID-19 and metabolic dysfunction associated fatty liver disease (MAFLD).The aim of this review is to analyse the effect of MAFLD on severity of COVID-19. METHODS: We systematically searched the PubMed database till May 20, 2020 and retrieved all the articles published on COVID-19 and fatty liver/MAFLD/NAFLD. RESULTS: Limited studies done had shown four to six fold high risk of severe COVID-19 in patients with MAFLD. Patients with MAFLD and associated obesity, severe fibrosis and age <60 yrs are more prone to develop severe COVID-19. CONCLUSION: MAFLD is associated with 4–6 fold increase in severity of COVID-19 compared to non MAFLD patients. Physician and hepatologist should follow these patients cautiously and preventive measures to be taken strictly in these high risk patients.
Search related documents:
Co phrase search for related documents- abnormal ast and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- abnormal ast and liver enzyme: 1, 2
- abnormal ast and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- abnormal ast and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- abnormal ast and lopinavir ritonavir: 1, 2, 3, 4
- abnormal ast and lymphocyte count: 1, 2
- abnormal liver and liver affect: 1, 2, 3, 4, 5, 6
- abnormal liver and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver and liver disorder: 1
- abnormal liver and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- abnormal liver and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver and liver present: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- abnormal liver and long discharge: 1
- abnormal liver and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- abnormal liver and lymphocyte count: 1, 2, 3, 4, 5, 6, 7
- abnormal liver function and liver affect: 1, 2, 3
- abnormal liver function and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abnormal liver function and liver disorder: 1
Co phrase search for related documents, hyperlinks ordered by date